The impact of accelerated high frequency rTMS on brain neurochemicals in treatment-resistant depression: Insights from 1H MR spectroscopy

Clin Neurophysiol. 2017 Sep;128(9):1664-1672. doi: 10.1016/j.clinph.2017.06.243. Epub 2017 Jul 6.

Abstract

Objective: Although accelerated repetitive transcranial magnetic stimulation (rTMS) designs seem to be able to alleviate mood over a relatively short period of time, no studies yet examined the cellular effects on neurochemicals with regard to working mechanisms, safety and neural integrity.

Methods: Eighteen right-handed antidepressant-free unipolar treatment resistant depressed (TRD) patients participated in this sham-controlled accelerated high frequency (aHF)-rTMS 1H MR spectroscopy study applied to the left dorsolateral prefrontal cortex (DLPFC). Baseline measurements were compared to eighteen age- and gender-matched healthy controls. We explicitly focused on neurochemical concentrations in the bilateral DLPFC and rostral anterior cingulate cortex (rACC).

Results: Compared to healthy individuals, TRD patients displayed significantly lower baseline glutamatergic (sum absolute concentrations glutamate and glutamine) concentrations in the left DLPFC. aHF-rTMS does not significantly alter neurochemical concentrations in the three predefined brain regions. Clinical improvement was related to significant GABA concentration increases in the left DLPFC.

Conclusions: Accelerated HF-rTMS treatment did not affect neural integrity in the examined regions. The observed GABA concentration increases suggest that the immediate therapeutic effects of aHF-rTMS could be mediated through a locally increased GABAergic inhibitory neurotransmission.

Significance: Although more statistical power is needed for reaching firm conclusions, aHF-rTMS does not appear to negatively influence neural integrity.

Keywords: (1)H MR spectroscopy; Accelerated HF-rTMS; Treatment resistant major depression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain / metabolism
  • Brain Chemistry / physiology*
  • Cerebral Cortex / chemistry*
  • Cerebral Cortex / metabolism*
  • Depressive Disorder, Treatment-Resistant / diagnosis
  • Depressive Disorder, Treatment-Resistant / metabolism*
  • Female
  • Humans
  • Magnetic Resonance Spectroscopy* / methods
  • Male
  • Middle Aged
  • Transcranial Magnetic Stimulation / methods*
  • Transcranial Magnetic Stimulation / trends
  • Treatment Outcome